Belite Bio Inc - American Depositary Shares — Cash Flow (NASDAQ:BLTE) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -11.46 M-29.84 M-29.23 M-36.99 M -139.84 M Cash from investing activities -394 K-63 K-110.57 M-305.11 M — Cash from financing activities 36.96 M75.96 M83.59 M663.23 M — Free cash flow -11.46 M-29.84 M-29.23 M-36.99 M -139.84 M

News

Belite Bio, Inc (BLTE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Belite Bio, Inc (BLTE) Presents at 27th Fundus Disease Forum and International Retinal Symposium (Retina China 2026) - Slideshow (NASDAQ:BLTE) 2026-05-27

Belite Bio, Inc (BLTE) Q1 2026 Earnings Call Transcript

Belite Bio, Inc (BLTE) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Belite Bio at Leerink Conference: Tinlarebant’s Promising Trials

Mizuho reiterates Belite Bio stock rating on NDA timeline update

H.C. Wainwright raises Belite Bio stock price target on NDA timeline

Belite Bio, Inc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:BLTE) 2026-03-03

Belite Bio stock price target raised to $217 by Benchmark on trial data

Cantor Fitzgerald raises Belite Bio stock price target on pricing outlook

Belite Bio, Inc (BLTE) Q4 2025 Earnings Call Transcript

Belite Bio stock hits all-time high at 177.28 USD